Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips integrates MedChat's AI capabilities to optimize automated patient communication and hospital workflows

Amazon

Deckers Outdoor

Starbucks

Every year, Oprah's Favorite Things boosts the bottom line of several brands. The latest list will help these five stocks stand out.

5 Lucky Stocks Set to Get an ‘Oprah's Favorite Things' Boost

STAMFORD, Conn., Nov. 16, 2021 /PRNewswire/ -- What happens when artificial intelligence (AI) is integrated into your grooming routine?

New Philips Norelco Shaver Series 9000 now features artificial intelligence for a smarter shaving experience

Philips advances ultrasound portfolio with new robust imaging tools and features for Radiology to increase diagnostic confidence and workflow efficiency

Koninklijke Philips shares tumbled 11% on Monday after the Food and Drug Administration published its inspection findings at a U.S. manufacturing facility in Pennsylvania.

Europe Markets: Philips shares reel after FDA releases findings from Pennsylvania plant inspection

Koninklijke Philips NV (NYSE: PHG) said it is in discussions with the FDA after a new inspection of one of its facilities. Philips in September estimated it would replace up to 4 million ventilators and respiratory devices because of a polyurethane foam part that might degrade and become toxic.

Philips Shares Slump After Update On Recall Of Respiratory, Sleep Devices

The stock price of Koninklijke Philips NV (NYSE: PHG) fell by over 10% pre-market today. This is why it happened.

Koninklijke Philips (PHG) Stock: Why The Price Fell Today

Koninklijke Philips PHIA, -9.27% PHG, +0.17% was on track for its worst single session in 19 years, falling 9.6%, after the Food and Drug Administration's inspection of a U.S. facility, following a recall of breathing assistance machines. The FDA said it obtained information during an inspection about the silicone-based foam used in a similar device marketed outside the U.S., which failed one safety test for the release of certain chemicals.

Philips shares tumble as FDA raises concern about silicone foam

Philips, the medical equipment maker that is recalling ventilators due to use of parts containing a potentially hazardous foam, said on Sunday it is in dicussions with the U.S. Food and Drug Administration (FDA) after a new inspection of one of the company's facilities.

Philips in discussions with FDA after new inspection findings - statement

Philips provides update on earlier announced voluntary CPAP, BiPAP and Mechanical Ventilator recall notification*

Philips receives grant to improve quality and accessibility of maternal care in low- and middle-income countries

Intravascular ultrasound (IVUS) linked with improved health outcomes in largest-ever real-world analysis of lower extremity peripheral vascular interventions

Philips to expand its cardiac diagnostics and monitoring portfolio with the acquisition of Cardiologs

TCT 2021: Philips announces new innovations and clinical data supporting the treatment of patients with cardiovascular disease

Philips Capsule Medical Device Information Platform reaches device integration milestone

Philips announces ambitious climate action to drive significant reduction of greenhouse gas emissions in its supply chain

Think of Philips as a turnaround story. Build a small position in the stock on any near-term pullback.

Philips: Patience Is Prescribed

Philips brings clarity to every moment of cancer care with new patient-centered innovations at ASTRO 2021

Koninklijke Philips N.V. (PHG) CEO Frans van Houten on Q3 2021 Results - Earnings Call Transcript

Koninklijke Philips NV (NYSE: PHG) reported third-quarter sales declined by 5.8% year-over-year to €4.16 billion, and a 7.6% comparable sales decline due to headwinds caused by global supply chain challenges and Sleep & Respiratory Care recall consequences. For the quarter, Comparable order intake increased by 47%.

Philips Stock Down After Q3 Results, Expects Supply Chain Volatility To Continue In Q4

Dutch electronics firm Philips said on Monday that sales had taken a fresh hit from a recall of faulty sleep and respiratory care equipment and from supply chain issues.

Philips takes fresh hit from safety recall

Philips now expects to report low-single-digit comparable sales growth

Koninklijke Philips NV reported on Monday a significant rise in net profit for the third quarter but suffered a decline in sales for the period, which also missed market views.

Philips Delivers Q3 Sales of EUR 4.2 Billion

Dutch health technology company Philips on Monday lowered its outlook for sales and profit growth in 2021, as a massive recall of respiratory devices and global shortage of electronic components hit its third-quarter earnings.

Philips lowers outlook as recall, parts shortages bite

Philips sees continued strong demand driving double-digit order intake growth in Q3

Philips delivers Q3 sales of EUR 4.2 billion, with a 7.6% comparable sales decline due to headwinds; income from continuing operations increases to EUR 442 million, and Adjusted EBITA margin amounts to 12.3%

News for Royal Philips Stock (PHG)